Results 171 to 180 of about 32,386 (229)

Unveiling the Therapeutic Potential of “Taikong Blue” Lavender Essential Oil and Its Key Compounds in Skin Problems via Network Pharmacology and In Vitro Validation

Journal of Cosmetic Dermatology, Volume 25, Issue 2, February 2026.
ABSTRACT Background Taikong Blue Lavender Essential Oil (TLEO) is derived from a proprietary space‐bred cultivar of Lavandula angustifolia and cultivated under pristine conditions in Xinjiang, China. TLEO has long been used by regional people to treat various skin disorders such as hyperpigmentation, trans‐epidermal water loss, collagen degradation ...
Fei Liu, Yingyu Zhang, Minhazul Abedin, Jingyi Song, Suzhen Yang, Hongxiang Lou, Xixi Dou, Junsong Xiao, Hua Wu   +8 more
wiley   +1 more source

The Role of TNF - α, IFN - γ, and IL-6 in Guiding Treatment and Predicting Prognosis in the Treatment of Severe Plaque Psoriasis with Adalimumab.

Indian J Dermatol
Zhang JQ, Zhang Y, Chen H, Sun HG.
europepmc   +1 more source

HLA Class II Alleles Are Associated With Anti‐Drug Antibodies in Ulcerative Colitis Patients Treated With Etrolizumab

HLA, Volume 107, Issue 2, February 2026.
ABSTRACT Patients treated with etrolizumab, a monoclonal antibody drug for ulcerative colitis, often develop anti‐drug antibodies (ADA) and neutralising antibodies (NAb). To investigate genetic risk factors, we evaluated associations between HLA alleles and ADA/NAb development. HLA‐DQB1*06:03 demonstrated the most significant association with both ADA (
Ashis Saha, Mark I. McCarthy, Saloumeh K. Fischer, Gizette Sperinde, Christian Hammer   +4 more
wiley   +1 more source

Bimekizumab Impact on Patient-Reported Outcomes in Plaque Psoriasis: 4-Year Results from BE SURE, BE VIVID, BE READY, and BE BRIGHT. [PDF]

Dermatol Ther (Heidelb)
Armstrong A, Papp KA, Lebwohl M, Savage LJ, Yamanaka K, Vlase DE, Warham R, Lambert J, López Pinto JM, Wixted K, Thaçi D.   +10 more
europepmc   +1 more source

Adoption of new treatment options in non-systemic juvenile idiopathic arthritis (JIA) in clinical practice. [PDF]

Pediatr Rheumatol Online J
Lamers HC, Van Nieuwenhove E, Vastert SJ, Jansen MHA, van Royen-Kerkhof A, Swart JF, de Roock S.   +6 more
europepmc   +1 more source

Advances in the Management of Pediatric Inflammatory Bowel Disease: From Biologics to Small Molecules. [PDF]

Pharmaceuticals (Basel)
Mucci B, Palazzolo E, Ruberti F, Ientile L, Natale M, Esposito S.   +5 more
europepmc   +1 more source

Best of United European Gastroenterology Week 2025

United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
Iuliana Nenu, Sara Nikolic, Eduardo Valdivielso, Giovanni Marasco   +3 more
wiley   +1 more source

Trends in immunomodulatory therapy for the treatment of chronic uveitis in the United States. [PDF]

J Ophthalmic Inflamm Infect
Zhang C, Ersan S, Lin JB, Cale M, Albini TA.   +4 more
europepmc   +1 more source

Pyoderma Gangrenosum with Biological Agents Therapy: A Systematic Review. [PDF]

Clin Cosmet Investig Dermatol
Tan B, Chen M, Hu X, He J, Zhang L, Du S, Mou Y, Xiong X, Duan X.   +8 more
europepmc   +1 more source